Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PPARG | P37231 | 8/20 | 0.97 |
| ▸ | CNR1 | P21554 | 2/20 | 0.97 |
| ▸ | CNR2 | P34972 | 2/20 | 0.97 |
| ▸ | TRPV1 | Q8NER1 | 2/20 | 0.97 |
| ▸ | SLC6A3 | Q01959 | 2/20 | 0.97 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.97 |
| ▸ | INHA | P05111 | 1/20 | 0.97 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.97 |
| ▸ | HTR2A | P28223 | 1/20 | 0.97 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.97 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.97 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.97 |
| ▸ | TRPM8 | Q7Z2W7 | 1/20 | 0.97 |
| ▸ | TRPV3 | Q8NET8 | 1/20 | 0.97 |
| ▸ | TRPV4 | Q9HBA0 | 1/20 | 0.97 |
| ▸ | TRPV2 | Q9Y5S1 | 1/20 | 0.97 |
| ▸ | TRPM7 | Q96QT4 | 1/20 | 0.61 |
| ▸ | DAGLA | Q9Y4D2 | 1/20 | 0.61 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.60 |
| ▸ | BACE1 | P56817 | 1/20 | 0.60 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23523558 | 1.00 | PPARG (0.97) | PPARGCNR1CNR2TRPV1SLC6A3 | |
| SCHEMBL23523451 | 1.00 | PPARG (0.97) | PPARGCNR1CNR2TRPV1SLC6A3 | |
| SCHEMBL23523493 | 1.00 | PPARG (0.97) | PPARGCNR1CNR2TRPV1SLC6A3 | |
| SCHEMBL23523454 | 1.00 | PPARG (0.97) | PPARGCNR1CNR2TRPV1SLC6A3 | |
| SCHEMBL23523643 | 1.00 | PPARG (0.97) | PPARGCNR1CNR2TRPV1SLC6A3 | |
| SCHEMBL23523554 | 1.00 | PPARG (0.97) | PPARGCNR1CNR2TRPV1SLC6A3 | |
| SCHEMBL23523642 | 1.00 | PPARG (0.97) | PPARGCNR1CNR2TRPV1SLC6A3 | |
| SCHEMBL23523040 | 1.00 | PPARG (0.97) | PPARGCNR1CNR2TRPV1SLC6A3 | |
| SCHEMBL23523492 | 1.00 | PPARG (0.97) | PPARGCNR1CNR2TRPV1SLC6A3 | |
| SCHEMBL23522965 | 1.00 | PPARG (0.97) | PPARGCNR1CNR2TRPV1SLC6A3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12433903-B2 | Cannabinoid derivatives and their use | DEMEETRA AGBIO, INC. (US) | 2025-10-07 | — | — | US | disclosed |
| US-11992497-B2 | Cannabinoid derivatives and their use | DEMEETRA AGBIO, INC. (US) | 2024-05-28 | — | — | US | disclosed |
| US-20230322654-A1 | CANNABINOID DERIVATIVES AND THEIR USE | DEMEETRA AGBIO, INC. | 2023-10-12 | — | — | US | disclosed |
| US-20230322654-A1 | CANNABINOID DERIVATIVES AND THEIR USE | DEMEETRA AGBIO, INC. | 2023-10-12 | — | — | US | disclosed |
| US-20230248748-A1 | CANNABINOID DERIVATIVES AND THEIR USE | DEMEETRA AGBIO, INC. | 2023-08-10 | — | — | US | disclosed |
| US-20230248748-A1 | CANNABINOID DERIVATIVES AND THEIR USE | DEMEETRA AGBIO, INC. | 2023-08-10 | — | — | US | disclosed |
| WO-2023133483-A1 | RECOMBINANT POLYPEPTIDES WITH BERBERINE BRIDGE ENZYME ACTIVITY USEFUL FOR THE BIOSYNTHESIS OF CANNABINOIDS | INVIZYNE TECHNOLOGIES, INC. (US) | 2023-07-13 | — | — | WO | disclosed |
| WO-2023069921-A1 | RECOMBINANT THCA SYNTHASE POLYPEPTIDES ENGINEERED FOR ENHANCED BIOSYNTHESIS OF CANNABINOIDS | EPIMERON USA, INC. (US) | 2023-04-27 | — | — | WO | disclosed |
| WO-2023023621-A1 | RECOMBINANT OLIVETOLIC ACID CYCLASE POLYPEPTIDES ENGINEERED FOR ENHANCED BIOSYNTHESIS OF CANNABINOIDS | WILLOW BIOSCIENCES, INC. (CA) | 2023-02-23 | — | — | WO | disclosed |
| WO-2023010083-A2 | RECOMBINANT PRENYLTRANSFERASE POLYPEPTIDES ENGINEERED FOR ENHANCED BIOSYNTHESIS OF CANNABINOIDS | WILLOW BIOSCIENCES, INC. (CA) | 2023-02-02 | — | — | WO | disclosed |
| US-20220403349-A1 | PRENYLTRANSFERASE VARIANTS WITH INCREASED THERMOSTABILITY | INVIZYNE TECHNOLOGIES, INC. (US) | 2022-12-22 | — | — | US | disclosed |
| US-11518983-B1 | Prenyltransferase variants with increased thermostability | INVIZYNE TECHNOLOGIES, INC. (US) | 2022-12-06 | — | — | US | disclosed |
| WO-2021195751-A1 | CATALYTIC CANNABIGEROL PROCESSES AND PRECURSORS | KARE CHEMICAL TECHNOLOGIES INC. (CA) | 2021-10-07 | — | — | WO | disclosed |
| US-20210189444-A1 | METHOD OF PURIFYING CANNABINOIDS FROM YEAST FERMENTATION BROTH | DEMETRIX, INC. | 2021-06-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12433903-B2 | Cannabinoid derivatives and their use | CNR1, CNR2, FAAH | PPARG 47/4885CNR1 1/4885CNR2 2/4885 |
| US-20230248748-A1 | CANNABINOID DERIVATIVES AND THEIR USE | CNR1, CNR2, FAAH | PPARG 47/4885CNR1 1/4885CNR2 2/4885 |
| US-11992497-B2 | Cannabinoid derivatives and their use | CNR1, CNR2, FAAH | PPARG 47/4885CNR1 1/4885CNR2 2/4885 |
| US-20230322654-A1 | CANNABINOID DERIVATIVES AND THEIR USE | CNR1, CNR2, FAAH | PPARG 47/4885CNR1 1/4885CNR2 2/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.